Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $26.70, with a market capitalization of 151.88B. The stock trades at a price-to-earnings (P/E) ratio of 19.37 and offers a dividend yield of 6.5%.
On 2026-04-30, Pfizer(PFE) stock traded between a low of $26.26 and a high of $26.91. Shares are currently priced at $26.70, which is +1.7% above the low and -0.8% below the high.
The Pfizer(PFE)'s current trading volume is 39.08M, compared to an average daily volume of 34.61M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.
PFE News
Pfizer (NYSE:PFE) has reached settlements with three generic manufacturers that extend US exclusivity for VYNDAMAX (tafamidis) until 2031. The agreements remov...
Key Points High-yield stocks may offer impressive levels of passive income -- but it’s important to understand why the particular stock is high-yield. Dividen...
Pfizer Inc. (NYSE:PFE) on Wednesday shared topline results from the late-stage study of its cancer treatment, ELREXFIO (elranatamab). Multiple myeloma is an agg...
Analyst ratings
50%
of 30 ratingsMore PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Pfizer (PFE) announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO as monotherapy in adults with relapsed or refractory mul...
If you are wondering whether Pfizer's current share price reflects its true worth, starting with the recent share performance and valuation checks can help fram...
Key Points Pfizer's growth rate has tanked in recent years, and investors remain concerned about the future. The company has been loading up on acquisitions t...
10:18 EDT BridgeBio (BBIO) jumps 12% to $83.18 as Pfizer (PFE) confirms tafamidis settlement Published first on TheFly – the ultimate source for real-time, mar...
Pfizer (PFE) announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regard...
Analyst Asad Haider of Goldman Sachs maintained a Hold rating on Pfizer, reducing the price target to $26.00. Claim 55% Off TipRanks Unlock hedge fund-level dat...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.